The COVID-19 Cytokine Storm; What We Know So Far

被引:1018
|
作者
Ragab, Dina [1 ]
Salah Eldin, Haitham [2 ]
Taeimah, Mohamed [3 ]
Khattab, Rasha [4 ]
Salem, Ramy [1 ]
机构
[1] Ain Shams Univ, Dept Clin Pathol, Fac Med, Cairo, Egypt
[2] Ain Shams Univ, Dept Chest Dis, Fac Med, Cairo, Egypt
[3] Ain Shams Univ, Fac Med, Dept Anesthesia Intens Care & Pain Management, Cairo, Egypt
[4] Ain Shams Univ, Dept Radiol, Fac Med, Cairo, Egypt
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
关键词
COVID-19; cytokine; storm; ARDS; IL-6;
D O I
10.3389/fimmu.2020.01446
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract resulting in pneumonia in most of the cases and acute respiratory distress syndrome (ARDS) in about 15 % of the cases. Mortality in COVID-19 patients has been linked to the presence of the so-called "cytokine storm" induced by the virus. Excessive production of proinflammatory cytokines leads to ARDS aggravation and widespread tissue damage resulting in multi-organ failure and death. Targeting cytokines during the management of COVID-19 patients could improve survival rates and reduce mortality.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Smoking and COVID-19: What we know so far
    Shastri, Madhur D.
    Shukla, Shakti D.
    Chong, Wai Chin
    Kc, Rajendra
    Dua, Kamal
    Patel, Rahul P.
    Peterson, Gregory M.
    O'Toole, Ronan F.
    [J]. RESPIRATORY MEDICINE, 2021, 176
  • [2] COVID-19 and cancer: what we know so far
    Sidaway, Peter
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (06) : 336 - 336
  • [3] COVID-19 and Myositis: What We Know So Far
    Saud, Ahmad
    Naveen, R.
    Aggarwal, Rohit
    Gupta, Latika
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2021, 23 (08)
  • [4] COVID-19 and Myositis: What We Know So Far
    Ahmad Saud
    R Naveen
    Rohit Aggarwal
    Latika Gupta
    [J]. Current Rheumatology Reports, 2021, 23
  • [5] COVID-19 and cancer: what we know so far
    Peter Sidaway
    [J]. Nature Reviews Clinical Oncology, 2020, 17 : 336 - 336
  • [6] Covid-19 and dizziness: what do we know so far?
    Mezzalira, Raquel
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (03) : 287 - 288
  • [7] COVID-19 and Hematology—What Do We Know So Far?
    Harshwardhan Khandait
    Garima Gandotra
    Sonali Sachdeva
    Courtney A. Kramer
    Derek Nye
    Reshma Golamari
    Rohit Jain
    [J]. SN Comprehensive Clinical Medicine, 2020, 2 (12) : 2631 - 2636
  • [8] Neuropsychiatric Disorders and COVID-19: What We Know So Far
    Majolo, Fernanda
    da Silva, Guilherme Liberato
    Vieira, Lucas
    Anli, Cetin
    Timmers, Luis Fernando Saraiva Macedo
    Laufer, Stefan
    Goettert, Marcia Ines
    [J]. PHARMACEUTICALS, 2021, 14 (09)
  • [9] What we know about covid-19 reinfection so far
    Stokel-Walker, Chris
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [10] COVID-19 and the liver: What do we know so far?
    Prashant Nasa
    George Alexander
    [J]. World Journal of Hepatology, 2021, 13 (05) : 522 - 532